Tone mix
Week by week 52 weeks
Share of Corcept Therapeutics Inc.'s 290 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 18, 2026 · tone +99Zacks Research Issues Optimistic Estimate for CORT Earnings+104
- Week of May 25, 2026 · tone +100Canaccord Genuity Group Issues Positive Forecast for Corcept Therapeutics (NASDAQ:CORT) Stock Price+103
- Week of Nov 3, 2025 · tone -25What Does Wall Street Think About Corcept Therapeutics (CORT)?-78
- Week of Jun 8, 2026 · tone +100Catalyst and Momentum Trials Data Fuels Optimism for Corcept Therapeutics (CORT)+70
- Week of Sep 28, 2026 · tone +100Strong Commercial Execution and Pipeline Opportunities Propel Corcept Therapeutics (CORT)+70
- Week of Jul 13, 2026 · tone +100Returns Matter: NUTX +214%, CORT +145%, GKOS +97% - Were These Biotech Stocks In Your Portfolio?+61
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Corcept Therapeutics Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | -33 |
| Last 30 sessions | 14 | +21 |
| Last 90 sessions | 42 | +21 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
2 headlines, average tone -50: 0 positive, 1 neutral and 1 negative. Showing all 2.
- seekingalpha.com · 1 outletCorcept Therapeutics plunges 20% on Genmab cancer data (CORT:NASDAQ)Negative
- www.tickerreport.com · 1 outletCorcept Therapeutics Incorporated $CORT Stock Position Boosted by Nisa Investment Advisors LLCNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Corcept Therapeutics plunges 20% on Genmab cancer data (CORT:NASDAQ) | seekingalpha.com | 1 | Negative |
| Corcept Therapeutics Incorporated $CORT Stock Position Boosted by Nisa Investment Advisors LLC | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletEnglebert Financial Advisers LLC Buys New Shares in Corcept Therapeutics Incorporated $CORTNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Englebert Financial Advisers LLC Buys New Shares in Corcept Therapeutics Incorporated $CORT | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 16, 2026
1 headline, average tone +95: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletCorcept Therapeutics Incorporated (NASDAQ:CORT) Stock Has Average Price Target of $138.17Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Has Average Price Target of $138.17 | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletCorcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head ContrastNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Corcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head Contrast | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone +98: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.equitybulls.com · 1 outletMastek and CORT Win ISG Paragon Partnership of the Year 2026 for North America, Recognizing a Decade of Digital TransformationPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Mastek and CORT Win ISG Paragon Partnership of the Year 2026 for North America, Recognizing a Decade of Digital Transformation | www.equitybulls.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Corcept Therapeutics Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.